Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Counterpoint: Adjuvant therapy in stage II colon cancer: pain not justified by the gain.

Van Loon K, Venook AP.

J Natl Compr Canc Netw. 2012 Nov 1;10(11):1379-86.

PMID:
23138166
2.

Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group.

Figueredo A, Charette ML, Maroun J, Brouwers MC, Zuraw L.

J Clin Oncol. 2004 Aug 15;22(16):3395-407. Epub 2004 Jun 15. Review.

PMID:
15199087
3.

Identification of patients with high-risk stage II colon cancer for adjuvant therapy.

Quah HM, Chou JF, Gonen M, Shia J, Schrag D, Landmann RG, Guillem JG, Paty PB, Temple LK, Wong WD, Weiser MR.

Dis Colon Rectum. 2008 May;51(5):503-7. doi: 10.1007/s10350-008-9246-z. Epub 2008 Mar 6.

PMID:
18322753
4.

American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.

Benson AB 3rd, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, Krzyzanowska MK, Maroun J, McAllister P, Van Cutsem E, Brouwers M, Charette M, Haller DG.

J Clin Oncol. 2004 Aug 15;22(16):3408-19. Epub 2004 Jun 15. Review.

PMID:
15199089
5.

Adjuvant therapy for stage II colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group.

Figueredo A, Germond C, Maroun J, Browman G, Walker-Dilks C, Wong S.

Cancer Prev Control. 1997 Dec;1(5):379-92.

PMID:
9765760
6.

Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials.

Sargent D, Sobrero A, Grothey A, O'Connell MJ, Buyse M, Andre T, Zheng Y, Green E, Labianca R, O'Callaghan C, Seitz JF, Francini G, Haller D, Yothers G, Goldberg R, de Gramont A.

J Clin Oncol. 2009 Feb 20;27(6):872-7. doi: 10.1200/JCO.2008.19.5362. Epub 2009 Jan 5.

7.

Current issues in adjuvant treatment of stage II colon cancer.

André T, Sargent D, Tabernero J, O'Connell M, Buyse M, Sobrero A, Misset JL, Boni C, de Gramont A.

Ann Surg Oncol. 2006 Jun;13(6):887-98. Epub 2006 Apr 14. Review.

PMID:
16614880
8.

Adjuvant therapy for colon cancer.

Aranha O, Benson AB 3rd.

Curr Gastroenterol Rep. 2007 Oct;9(5):415-21. Review.

PMID:
17991344
9.

Point: Treating stage II colon cancer: the quest for personalized adjuvant care.

Vergo MT, Benson AB 3rd.

J Natl Compr Canc Netw. 2012 Nov 1;10(11):1370-4.

PMID:
23138165
10.

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

Gill S, Loprinzi CL, Sargent DJ, Thomé SD, Alberts SR, Haller DG, Benedetti J, Francini G, Shepherd LE, Francois Seitz J, Labianca R, Chen W, Cha SS, Heldebrant MP, Goldberg RM.

J Clin Oncol. 2004 May 15;22(10):1797-806. Epub 2004 Apr 5.

PMID:
15067028
11.

Effect of preoperative neutrophil-lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy.

Hung HY, Chen JS, Yeh CY, Changchien CR, Tang R, Hsieh PS, Tasi WS, You JF, You YT, Fan CW, Wang JY, Chiang JM.

Int J Colorectal Dis. 2011 Aug;26(8):1059-65. doi: 10.1007/s00384-011-1192-x. Epub 2011 Apr 9.

PMID:
21479566
12.

Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials.

Sargent DJ, Wieand HS, Haller DG, Gray R, Benedetti JK, Buyse M, Labianca R, Seitz JF, O'Callaghan CJ, Francini G, Grothey A, O'Connell M, Catalano PJ, Blanke CD, Kerr D, Green E, Wolmark N, Andre T, Goldberg RM, De Gramont A.

J Clin Oncol. 2005 Dec 1;23(34):8664-70. Epub 2005 Oct 31.

PMID:
16260700
13.

Adjuvant therapy for colon cancer.

Macdonald JS.

CA Cancer J Clin. 1997 Jul-Aug;47(4):243-56.

14.

A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer.

Schippinger W, Samonigg H, Schaberl-Moser R, Greil R, Thödtmann R, Tschmelitsch J, Jagoditsch M, Steger GG, Jakesz R, Herbst F, Hofbauer F, Rabl H, Wohlmuth P, Gnant M, Thaler J; Austrian Breast and Colorectal Cancer Study Group.

Br J Cancer. 2007 Oct 22;97(8):1021-7. Epub 2007 Sep 25.

15.

Prognostic factors in patients with isolated recurrences of breast cancer (stage IV-NED).

Juan O, Lluch A, de Paz L, Prósper F, Azagra P, Marugán I, Martínez-Agulló A, Garcia-Conde J.

Breast Cancer Res Treat. 1999 Jan;53(2):105-12.

PMID:
10326787
16.

Adjuvant Therapy for Stage II Colorectal Cancer: Who and with What?

Chung KY, Kelsen D.

Curr Treat Options Gastroenterol. 2006 Jun;9(3):272-80.

PMID:
16901391
17.

Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set.

O'Connell MJ, Campbell ME, Goldberg RM, Grothey A, Seitz JF, Benedetti JK, André T, Haller DG, Sargent DJ.

J Clin Oncol. 2008 May 10;26(14):2336-41. doi: 10.1200/JCO.2007.15.8261.

PMID:
18467725
18.

Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.

Kim ST, Lee J, Park SH, Park JO, Lim HY, Kang WK, Kim JY, Kim YH, Chang DK, Rhee PL, Kim DS, Yun H, Cho YB, Kim HC, Yun SH, Lee WY, Chun HK, Park YS.

Cancer Chemother Pharmacol. 2010 Sep;66(4):659-67. doi: 10.1007/s00280-009-1206-3. Epub 2009 Dec 24.

PMID:
20033812
19.

Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patients.

Westra JL, Schaapveld M, Hollema H, de Boer JP, Kraak MM, de Jong D, ter Elst A, Mulder NH, Buys CH, Hofstra RM, Plukker JT.

J Clin Oncol. 2005 Aug 20;23(24):5635-43.

PMID:
16110022
20.

Is adjuvant chemotherapy beneficial to high risk stage II colon cancer? Analysis in a single institute.

Lin CC, Lin JK, Chang SC, Wang HS, Yang SH, Jiang JK, Chen WS, Lin TC.

Int J Colorectal Dis. 2009 Jun;24(6):665-76. doi: 10.1007/s00384-009-0634-1. Epub 2009 Feb 24.

PMID:
19238405

Supplemental Content

Support Center